Symbyax and Actos drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Symbyax (fluoxetine hydrochloride; olanzapine) and Actos (pioglitazone hydrochloride). Common drug interactions include carpal tunnel decompression among females and weight increased among males.

The phase IV clinical study analyzes what interactions people have when they take Symbyax and Actos. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Symbyax?

Symbyax has active ingredients of fluoxetine hydrochloride; olanzapine. It is often used in depression. eHealthMe is studying from 1,449 Symbyax users. Check the latest studies of Symbyax.

What is Actos?

Actos has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 49,754 Actos users. Check the latest studies of Actos.



On Jul, 11, 2026

30 people who take Symbyax and Actos together, and have interactions are studied.

Symbyax and Actos drug interactions.

What are the common drug interactions of Symbyax and Actos, by gender? *:

female:

  1. Carpal tunnel decompression
  2. Cataract (clouding of the lens inside the eye)
  3. Cellulitis (infection under the skin)
  4. Cellulitis orbital (acute spread of infection into the eye socket)
  5. Conjunctivitis (pink eye)
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Diabetic complication
  8. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Gestational diabetes (diabetes in pregnancy)

male:

  1. Weight increased
  2. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  3. Diabetes mellitus inadequate control
  4. Loss of consciousness
  5. Psychotic disorder
  6. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  7. Aggression
  8. Asthenia (weakness)
  9. Constipation
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the common drug interactions of Symbyax and Actos, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Obesity (having too much body fat)

30-39:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Diabetic nephropathy (diabetic kidney disease)
  3. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  4. Obesity (having too much body fat)
  5. Renal failure (kidney dysfunction)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Diabetes mellitus inadequate control
  8. Neuropathy peripheral (surface nerve damage)
  9. Nephropathy (damage to or disease of a kidney)
  10. Organic erectile dysfunction (inability to achieve or maintain an erection long enough to engage in sexual intercourse)

40-49:

  1. Cellulitis orbital (acute spread of infection into the eye socket)
  2. Conjunctivitis (pink eye)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Diabetes mellitus inadequate control
  5. Diabetic complication
  6. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Gestational diabetes (diabetes in pregnancy)
  9. Glycosuria (excretion of glucose into the urine)
  10. Hospitalisation

50-59:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Bladder discomfort
  5. Cardiac disorder
  6. Cardiomyopathy (weakening of the heart muscle)
  7. Chest pain
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Coeliac disease (simple food intolerance)
  10. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

60+:

  1. Blood creatine phosphokinase increased
  2. Weight increased
  3. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  4. Depressed level of consciousness
  5. Haematocrit decreased
  6. Haematuria (presence of blood in urine)
  7. Haemoglobin decreased
  8. Hallucination (an experience involving the perception of something not present)
  9. Incontinence (lack of moderation or self-control)
  10. Lymphocyte count decreased

What are the existing conditions these people have? *

  1. Bipolar Disorder (mood disorder): 8 people, 26.67%
  2. Affective Disorder (mental disorder): 6 people, 20.00%
  3. Agitation (state of anxiety or nervous excitement): 6 people, 20.00%
  4. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 6 people, 20.00%
  5. Stress And Anxiety: 4 people, 13.33%
  6. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 10.00%
  7. Type 2 Diabetes: 3 people, 10.00%
  8. Peptic Ulcer Haemorrhage (peptic ulcer bleeding): 2 people, 6.67%
  9. Parkinson's Disease: 2 people, 6.67%
  10. Neuropathy Peripheral (surface nerve damage): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Symbyax and Actos?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Symbyax and Actos:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Symbyax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Actos:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Symbyax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actos and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluoxetine hydrochloride; olanzapine and pioglitazone hydrochloride (the active ingredients of Symbyax and Actos, respectively), and Symbyax and Actos (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: